home / stock / kod / kod news

KOD News and Press, Kodiak Sciences Inc From 10/02/19

Stock Information
Company Name: Kodiak Sciences Inc
Stock Symbol: KOD
Market: NASDAQ
Website: kodiak.com
Menu
KOD KOD Quote KOD Short KOD News KOD Articles KOD Message Board
Get KOD Alerts

News, Short Squeeze, Breakout and More Instantly...
KOD - 3 Top Biotech Stocks to Buy in October

Over the past three months, the Nasdaq Biotechnology index has tumbled around 9.5% and industrywide worries have pressured share prices of some companies that didn't deserve a market beatdown. Axsome Therapeutics (NASDAQ: AXSM) , BridgeBio Pharma (NASDAQ: BBIO) , and Kodiak Sciences (...
KOD - 3 Biotech Stocks That Soared Last Week

The biotech industry's summer doldrums are finally over and a handful of stocks recently posted some big gains for different reasons. Should we expect more gains ahead from these drugmakers or have they reached a peak? Let's look at what drove these biotech stocks higher during the week ended...

KOD - Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting

PALO ALTO, Calif. , Sept. 15, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced emerging durability data in patients with wet age-r...

KOD - Kodiak Sciences to Release Durability Data from Clinical Development Program of KSI-301 for wet AMD at The Retina Society Annual Meeting

PALO ALTO, Calif. , Sept. 12, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that updated data from the clinical development program ...
KOD - Kodiak Sciences to Present at the Morgan Stanley Global Healthcare Conference

PALO ALTO, Calif. , Sept. 6, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that management will participate in the Morgan Stanl...

KOD - Kodiak Sciences Announces Upcoming Presentations at EURETINA Meeting

PALO ALTO, Calif. , Sept. 4, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that presentations on its research will be made at E...

KOD - Kodiak Sciences (KOD) Investor Presentation - Slideshow

The following slide deck was published by Kodiak Sciences Inc. in conjunction with this Read more ...

KOD - Kodiak Sciences EPS misses by $0.02

Kodiak Sciences (NASDAQ: KOD ): Q2 GAAP EPS of -$0.31 misses by $0.02 . More news on: Kodiak Sciences Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

KOD - Kodiak Sciences Announces Second Quarter 2019 Financial Results and Recent Business Highlights

PALO ALTO, Calif. , Aug. 14, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today reported business highlights and financial results for the sec...

KOD - Kodiak Sciences to Present at Wedbush PacGrow Healthcare Conference

PALO ALTO, Calif. , Aug. 8, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that management will present at the Wedbush PacGrow H...
Previous 10 Next 10